Well #1 Expenses including R&D have increased every year for the past 10years. I don't know how one can attest to this one? Look at our AGM expenditures. I'm not saying they shouldn't be spending this cash, but the point was they have burnt through over 100million in cash that is a fact. Perhaps look through the past Cash Raises to refresh your memory on how much cash we had and kept needing to raise.
#2 Gone backward from Phase 2 trials to Phase 1. To which you respond with "that's your view". Do tell, what Phase 2 trails is Imugene currently running that is not Hervax which is on life support? If you recall the recent aZErCeLl purchase has Phase 1 trials penned in to BEGIN in 2025/2026. So yes, you are incorrect in your rebuttals. Perhaps increase the value in your points please
Why IMU is NOT a MULTI Bagger is a BAGGIES company, page-73
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |